Dual regulation of TxNIP by ChREBP and FoxO1 in liver
- PMID: 33748706
- PMCID: PMC7966993
- DOI: 10.1016/j.isci.2021.102218
Dual regulation of TxNIP by ChREBP and FoxO1 in liver
Abstract
TxNIP (Thioredoxin-interacting protein) is considered as a potential drug target for type 2 diabetes. Although TxNIP expression is correlated with hyperglycemia and glucotoxicity in pancreatic β cells, its regulation in liver cells has been less investigated. In the current study, we aim at providing a better understanding of Txnip regulation in hepatocytes in response to physiological stimuli and in the context of hyperglycemia in db/db mice. We focused on regulatory pathways governed by ChREBP (Carbohydrate Responsive Element Binding Protein) and FoxO1 (Forkhead box protein O1), transcription factors that play central roles in mediating the effects of glucose and fasting on gene expression, respectively. Studies using genetically modified mice reveal that hepatic TxNIP is up-regulated by both ChREBP and FoxO1 in liver cells and that its expression strongly correlates with fasting, suggesting a major role for this protein in the physiological adaptation to nutrient restriction.
Keywords: Endocrinology; Molecular Biology; Molecular Physiology.
© 2021.
Conflict of interest statement
The authors declare no conflict of interest.
Figures









Similar articles
-
FOXO1 competes with carbohydrate response element-binding protein (ChREBP) and inhibits thioredoxin-interacting protein (TXNIP) transcription in pancreatic beta cells.J Biol Chem. 2013 Aug 9;288(32):23194-202. doi: 10.1074/jbc.M113.473082. Epub 2013 Jun 26. J Biol Chem. 2013. PMID: 23803610 Free PMC article.
-
Celastrol targets the ChREBP-TXNIP axis to ameliorates type 2 diabetes mellitus.Phytomedicine. 2023 Feb;110:154634. doi: 10.1016/j.phymed.2022.154634. Epub 2022 Dec 27. Phytomedicine. 2023. PMID: 36603341
-
New Insight Into Metformin Action: Regulation of ChREBP and FOXO1 Activities in Endothelial Cells.Mol Endocrinol. 2015 Aug;29(8):1184-94. doi: 10.1210/ME.2015-1090. Epub 2015 Jul 6. Mol Endocrinol. 2015. PMID: 26147751 Free PMC article.
-
The physiological and pathophysiological roles of carbohydrate response element binding protein in the kidney.Endocr J. 2022 Jun 28;69(6):605-612. doi: 10.1507/endocrj.EJ22-0083. Epub 2022 Apr 26. Endocr J. 2022. PMID: 35474028 Review.
-
Overview on Thioredoxin-Interacting Protein (TXNIP): A Potential Target for Diabetes Intervention.Curr Drug Targets. 2022;23(7):761-767. doi: 10.2174/1389450123666220303092324. Curr Drug Targets. 2022. PMID: 35240955 Review.
Cited by
-
The role of TXNIP in cancer: a fine balance between redox, metabolic, and immunological tumor control.Br J Cancer. 2023 Dec;129(12):1877-1892. doi: 10.1038/s41416-023-02442-4. Epub 2023 Oct 4. Br J Cancer. 2023. PMID: 37794178 Free PMC article. Review.
-
Thioredoxin-interacting protein: A new therapeutic target in bone metabolism disorders?Front Immunol. 2022 Aug 17;13:955128. doi: 10.3389/fimmu.2022.955128. eCollection 2022. Front Immunol. 2022. PMID: 36059548 Free PMC article. Review.
-
Role of Carbohydrate response element-binding protein in mediating dexamethasone-induced glucose transporter 5 expression in Caco-2BBE cells and during the developmental phase in mice.Anim Cells Syst (Seoul). 2024 Jan 4;28(1):15-24. doi: 10.1080/19768354.2023.2301009. eCollection 2024. Anim Cells Syst (Seoul). 2024. PMID: 38192641 Free PMC article.
-
Phenolics-Rich Extracts of Dietary Plants as Regulators of Fructose Uptake in Caco-2 Cells via GLUT5 Involvement.Molecules. 2021 Aug 5;26(16):4745. doi: 10.3390/molecules26164745. Molecules. 2021. PMID: 34443333 Free PMC article.
-
In-depth phosphoproteomic profiling of the insulin signaling response in heart tissue and cardiomyocytes unveils canonical and specialized regulation.Cardiovasc Diabetol. 2024 Jul 18;23(1):258. doi: 10.1186/s12933-024-02338-4. Cardiovasc Diabetol. 2024. PMID: 39026321 Free PMC article.
References
-
- Abdul-Wahed A., Guilmeau S., Postic C. Sweet sixteenth for ChREBP: established roles and future goals. Cell Metab. 2017;26:324–341. - PubMed
-
- Bedarida T., Baron S., Vibert F., Ayer A., Henrion D., Thioulouse E., Marchiol C., Beaudeux J.L., Cottart C.H., Nivet-Antoine V. Resveratrol decreases TXNIP mRNA and protein nuclear expressions with an arterial function improvement in old mice. J. Gerontol. A. Biol. Sci. Med. Sci. 2016;71:720–729. - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous